If considering fasting approaches, patients taking insulin or sulfonylureas should consult their healthcare provider due to hypoglycemia risk
Affordable, regulated versions of Ozempic, the well-known diabetes and weight-loss shot from Novo Nordisk, are about to hit markets around the world, which could shake up the obesity drug scene
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis
Statements Author contributions Conceptualization, YW
10.1152/ajpendo.00371.2018 329 ZhangN.YangX.YuanF.ZhangL.WangY.WangL.et al
However, other weight loss drugs may be less safe